Sugammadex Injection, Solution
Product Images NDC 55579-893

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 55579-893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solupharm Pharmazeutische Erzeugnisse Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 01)

Chemical structure diagram of sugammadex, showing a cyclic molecule with multiple sodium carboxylate groups and thiol substituents, consistent with the active ingredient SUGAMMADEX used in intravenous injection solution.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 02)

Chemical structure diagram of SUGAMMADEX, the active ingredient in the injection solution. The diagram shows a macrocyclic compound with multiple sugar moieties and sulfur atoms, presenting its complex molecular arrangement.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 03)

A cumulative recovery rate chart comparing recovery times over 120 minutes for sugammadex 2 mg/kg and neostigmine 0.05 mg/kg after rocuronium administration. The graph shows a faster recovery rate for sugammadex with a median time around 1.4 minutes, while neostigmine shows a slower recovery with a median around 21.5 minutes.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 04)

A cumulative recovery rate plot showing time to recovery in minutes for sugammadex 2 mg/kg versus neostigmine 0.05 mg/kg in patients receiving vecuronium. The graph demonstrates a faster recovery rate with sugammadex compared to neostigmine, with median recovery times noted as 2.1 minutes for sugammadex and 29.0 minutes for neostigmine.*

FDA Label Image

Label2 (Label2)

Sugammadex Injection 500 mg/5 mL (100 mg/mL) intravenous solution packaging label showing a carton containing 10 single-dose 5 mL vials. The label states prescription use only, storage instructions, and manufacturer Somerset Therapeutics LLC. Also includes a smaller vial label for a 5 mL single-dose vial with matching information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.